| |
| |
|
| Insider
Information: |
Crotty Robert |
| Relationship: |
Gen Counsel & Corp Sec... |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
139,049 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$16,222 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
139,049 |
|
|
| Total
Value |
$16,222 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dendreon Corp |
DNDN |
EVP, General Counsel |
2015-02-17 |
97,855 |
|
0 |
Premium* |
|
|
Nabriva Therapeutics AG |
NBRV |
Gen Counsel & Corp Sec... |
2021-08-31 |
41,194 |
2018-05-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
46 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNDN |
Dendreon Corp |
VP, Interim General Counsel |
• – – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
128,183 |
0 |
- |
|
| DNDN |
Dendreon Corp |
VP, Interim General Counsel |
• – – |
2014-02-28 |
4 |
D |
$2.88 |
$11,390 |
D/D |
(3,955) |
124,228 |
0 |
- |
|
| DNDN |
Dendreon Corp |
VP, Interim General Counsel |
• – – |
2014-04-30 |
4 |
D |
$2.58 |
$1,184 |
D/D |
(459) |
123,769 |
0 |
- |
|
| DNDN |
Dendreon Corp |
EVP, General Counsel |
• – – |
2014-05-31 |
4 |
D |
$2.16 |
$1,970 |
D/D |
(912) |
122,857 |
0 |
- |
|
| DNDN |
Dendreon Corp |
EVP, General Counsel |
• – – |
2014-07-31 |
4 |
D |
$2.07 |
$977 |
D/D |
(472) |
122,385 |
0 |
- |
|
| DNDN |
Dendreon Corp |
EVP, General Counsel |
• – – |
2014-08-31 |
4 |
D |
$1.36 |
$1,240 |
D/D |
(912) |
121,473 |
0 |
- |
|
| DNDN |
Dendreon Corp |
EVP, General Counsel |
• – – |
2014-10-31 |
4 |
D |
$0.98 |
$462 |
D/D |
(472) |
121,001 |
0 |
- |
|
| DNDN |
Dendreon Corp |
EVP, General Counsel |
• – – |
2014-11-30 |
4 |
D |
$0.14 |
$126 |
D/D |
(912) |
120,089 |
0 |
- |
|
| DNDN |
Dendreon Corp |
EVP, General Counsel |
• – – |
2015-01-31 |
4 |
D |
$0.16 |
$75 |
D/D |
(470) |
119,619 |
0 |
- |
|
| DNDN |
Dendreon Corp |
EVP, General Counsel |
• – – |
2015-02-17 |
4 |
S |
$0.08 |
$1,765 |
D/D |
(21,764) |
97,855 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
General Counsel & Secretary |
• – – |
2018-05-23 |
4 |
B |
$4.48 |
$44,800 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2019-08-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,250 |
27,036 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2019-08-21 |
4 |
D |
$2.08 |
$7,898 |
D/D |
(3,797) |
23,239 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2019-08-21 |
4/A |
S |
$2.08 |
$7,898 |
D/D |
(3,797) |
23,239 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2020-01-31 |
4 |
D |
$1.35 |
$5,254 |
D/D |
(3,892) |
83,097 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2020-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
105,000 |
188,097 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2020-02-28 |
4 |
D |
$1.35 |
$494 |
D/D |
(366) |
199,276 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2020-03-31 |
4 |
D |
$0.58 |
$210 |
D/D |
(366) |
198,883 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2020-04-30 |
4 |
D |
$0.55 |
$201 |
D/D |
(366) |
198,517 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2020-05-31 |
4 |
D |
$1.14 |
$417 |
D/D |
(366) |
198,151 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2020-06-30 |
4 |
D |
$0.67 |
$247 |
D/D |
(366) |
197,785 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2020-07-31 |
4 |
D |
$0.76 |
$278 |
D/D |
(366) |
197,419 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2020-08-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,250 |
208,669 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2020-08-20 |
4 |
D |
$0.65 |
$2,434 |
D/D |
(3,759) |
204,910 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Gen Counsel & Corp Secretary |
• – – |
2020-08-31 |
4 |
D |
$0.62 |
$227 |
D/D |
(366) |
204,544 |
0 |
- |
|
46 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
